Clinical research presents health care providers with information on the natural history and clinical presentations of disease as well as diagnostic and treatment options. In today's healthcare system, patients, physicians, clinicians and family caregivers often lack the sufficient scientific data and evidence they need to determine the best course of treatment for the patients' medical conditions. Initial National Priorities for Comparative Effectiveness Research(CER) is designed to fill this knowledge gap by assisting patients and healthcare providers across diverse settings in making more informed decisions. In this 2009 report, the Institute of Medicine's Committee on Comparative Effectiveness Research Prioritization establishes a working definition of CER, develops a priority list of research topics, and identifies the necessary requirements to support a robust and sustainable CER enterprise.
As part of the 2009 American Recovery and Reinvestment Act, Congress appropriated $1.1 billion in federal support of CER, reflecting legislators' belief that better decisions about the use of health care could improve the public's health and reduce the cost of care. The Committee on Comparative Effectiveness Research Prioritization was successful in preparing a list 100 top priority CER topics and 10 recommendations for best practices in the field.
Table of Contents
|2 What Is Comparative Effectiveness Research?||29-60|
|3 Obtaining Input to Identify National Priorities for Comparative Effectiveness Research||61-76|
|4 The Criteria and Process for Setting Priorities||77-96|
|5 Priorities for Study||97-138|
|6 Essential Priorities for a Robust CER Enterprise||139-166|
|Appendix A: Public Meeting Agenda - March 20, 2009||167-170|
|Appendix B: Stakeholder Questionnaire||171-188|
|Appendix C: Data Tables: Burden of Disease and Variation of Care||189-198|
|Appendix D: Cardiovascular and Peripheral Vascular Cover Sheet||199-202|
|Appendix E: Definitions of Medical Terminology in CER Priority List||203-212|
|Appendix F: Committee Biographies||213-228|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Initial National Priorities for Comparative Effectiveness Research...